Abstract
Shumei Wu, Fen Liu, Weiming Hu
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The liver
10.1016/j.cub.2017.09.019 · 2017
Neurobiological effects of binge drinking help in its detection and differential diagnosis from alcohol dependence
10.1155/2018/5623683 · 2018
The relationship between different dimensions of alcohol use and the burden of disease—an update
10.1111/add.13757 · 2017
A narrative review of alcohol consumption as a risk factor for global burden of disease
10.1186/s13011-016-0081-2 · 2016
Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008–2013: a nationwide retrospective cohort study
10.1016/j.jhep.2017.03.031 · 2017
The global burden of liver disease
10.1016/j.cgh.2023.04.015 · 2023
Steatotic liver disease: metabolic dysfunction, alcohol, or both?
10.3390/biomedicines11082108 · 2023
Dietary cholesterol in alcohol-associated liver disease
10.1097/in9.0000000000000026 · 2023
Genetic and epigenetic modifiers of alcoholic liver disease
10.3390/ijms19123857 · 2018
Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease
10.3748/wjg.v20.i26.8393 · 2014
ACG clinical guideline: alcoholic liver disease
10.1038/ajg.2017.469 · 2018
Alcohol control policy and changes in alcohol-related traffic harm
10.1111/add.14796 · 2019
Neuroplasticity in human alcoholism: studies of extended abstinence with potential treatment implications
10.35946/arcr.v37.1.09 · 2015
6H2L, a novel synthetic derivative of bifendate, induces apoptosis in hepatoma cells via mitochondrial and MAPK pathway
10.1016/j.ejphar.2020.173299 · 2020
The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis
10.1007/s10637-006-9001-z · 2006
Mori fructus aqueous extracts attenuates liver injury by inhibiting ferroptosis via the Nrf2 pathway
10.1186/s40104-023-00845-0 · 2023
Indian herbal medicines in the treatment of liver diseases: problems and promises
10.1111/j.1472-8206.2011.01011.x · 2011
A review of traditional uses, phytochemistry and pharmacology of Portulaca oleracea L
10.1016/j.jep.2017.05.004 · 2017
Evaluation of antioxidant compounds, antioxidant activities, and mineral composition of 13 collected purslane (Portulaca oleracea L.) accessions
10.1155/2014/296063 · 2014
Phenolic compound profile of selected vegetables frequently consumed by African Americans in the southeast United States
10.1016/j.foodchem.2006.10.077 · 2007
Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer
10.1016/j.lfs.2003.09.047 · 2004
HM-chromanone suppresses hepatic glucose production via activation of AMP-activated protein kinase in HepG2 cell
10.1016/j.ejphar.2022.175108 · 2022
Purslane extract and glucose homeostasis in adults with type 2 diabetes: a double-blind, placebo-controlled clinical trial of efficacy and safety
10.1089/jmf.2015.0090 · 2016
Portulaca oleracea reduces triglyceridemia, cholesterolemia, and improves lecithin: cholesterol acyltransferase activity in rats fed enriched-cholesterol diet
10.1016/j.phymed.2014.07.010 · 2014
Evaluation of the gastric antiulcerogenic effects of Portulaca oleracea L. extracts in mice
10.1002/ptr.1463 · 2004
Protective effects of ethanol extract from Portulaca oleracea L on dextran sulphate sodium-induced mice ulcerative colitis involving anti-inflammatory and antioxidant
2016
The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. Sativa (Haw.) Celak
10.1016/s0378-8741(00)00318-4 · 2000
Detection of antifungal activity in Portulaca oleracea by a single-cell bioassay system
10.1002/1099-1573(200008)14:5<329::aid-ptr581>3.0.co;2-5 · 2000
Antiviral activity of Portulaca oleracea L. against influenza A viruses
10.1016/j.jep.2019.112013 · 2019
Portulaca oleracea seed oil exerts cytotoxic effects on human liver cancer (HepG2) and human lung cancer (A-549) cell lines
10.7314/apjcp.2015.16.8.3383 · 2015
Antiulcerogenic effect of ethanolic extract of Portulaca oleracea experimental study
2010
The therapeutic effects of Portulaca oleracea L. in hepatogastric disorders
10.1016/j.gastrohep.2018.07.016 · 2019
Extracts of Portulaca oleracea promote wound healing by enhancing angiology regeneration and inhibiting iron accumulation in mice
10.1016/j.chmed.2021.09.014 · 2022
Effects of hydroalcoholic extracts of Portulaca pilosa and Achyrocline satureioides on urinary sodium and potassium excretion
10.1016/0378-8741(94)90040-x · 1994
Ameliorative effects of Portulaca oleracea L. (purslane) on the metabolic syndrome: a review
10.1016/j.jep.2022.115672 · 2022
In vitro cytotoxic and antiproliferative effects of Portulaca oleracea methanol extract on breast, cervical, colon and nasopharyngeal cancerous cell lines
10.11158/saa.10.1.7 · 2013
Comparison of various solvent extracts and major bioactive components from Portulaca oleracea for antioxidant, anti-tyrosinase, and anti-α-glucosidase activities
10.3390/antiox11020398 · 2022
Nanocarrier-mediated antioxidant delivery for liver diseases
10.7150/thno.38834 · 2020
Oxidative stress as a crucial factor in liver diseases
10.3748/wjg.v20.i25.8082 · 2014
Cytotoxicity assessments of Portulaca oleracea and Petroselinum sativum seed extracts on human hepatocellular carcinoma cells (HepG2)
10.7314/apjcp.2014.15.16.6633 · 2014
Effect of purslane on blood lipids and glucose: a systematic review and meta-analysis of randomized controlled trials
10.1002/ptr.6203 · doi-reference
The effects of Portulaca supplementation on antioxidant biomarkers and oxidative stress in non-active girls
10.29252/jmp.4.72.255 · doi-reference
Effect of Portulaca oleracea L. extract on functional constipation
10.4103/sjg.sjg_400_21 · doi-reference
Effect of Portulaca oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: a randomized, double-blind clinical trial
10.1002/ptr.6972 · doi-reference
The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial
10.1002/ptr.6342 · doi-reference
Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy
10.1016/j.jep.2011.06.020 · doi-reference
Iron accumulation in alcoholic liver diseases
10.1097/01.alc.0000189274.00479.62 · doi-reference
Ferroptosis in liver disease: new insights into disease mechanisms
10.1038/s41420-021-00660-4 · doi-reference
Dysregulation of systemic iron metabolism in alcoholic liver diseases
10.1111/j.1440-1746.2007.05290.x · doi-reference
Ferroptosis: past, present and future
10.1038/s41419-020-2298-2 · doi-reference
Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
10.3389/fphar.2022.946360 · doi-reference
Cytokine regulation of human sterol 12α-hydroxylase (CYP8B1) gene
10.1152/ajpgi.00207.2004 · doi-reference
Hepatic thyroid hormone signalling modulates glucose homeostasis through the regulation of GLP-1 production via bile acid-mediated FXR antagonism
10.1038/s41467-022-34258-w · doi-reference
G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes
10.1016/j.apsb.2022.10.011 · doi-reference
Fibrates and cholestasis
10.1002/hep.27744 · doi-reference
Plasma mannose-binding lectin is stimulated by PPARα in humans
10.1152/ajpendo.00299.2011 · doi-reference
Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1–3 genes
10.1016/j.molimm.2005.06.033 · doi-reference
EMR1/ADGRE1 expression in cancer cells upregulated by tumor-associated macrophages is related to poor prognosis in colorectal cancer
10.3390/biomedicines10123121 · doi-reference
Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases
10.1016/j.redox.2019.101263 · doi-reference
Inflammation-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
10.2147/ijgm.s354349 · doi-reference
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation
10.1016/j.jhep.2018.01.008 · doi-reference
Lack of interleukin-1α in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice
10.1016/j.dld.2014.01.156 · doi-reference
Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors
10.1093/toxsci/kfu065 · doi-reference
Organ-specific expression of IL-1 receptor results in severe liver injury in type Ⅰ interferon receptor deficient mice
10.3389/fimmu.2019.01009 · doi-reference
High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis
10.3233/cbm-170091 · doi-reference
A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma
10.21037/jgo.2016.04.01 · doi-reference
Preclinical characterization of RSM-932A, a novel anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells
10.1158/1535-7163.mct-14-0531 · doi-reference
Choline kinase α mediates interactions between the epidermal growth factor receptor and mechanistic target of rapamycin complex 2 in hepatocellular carcinoma cells to promote drug resistance and xenograft tumor progression
10.1053/j.gastro.2016.12.033 · doi-reference
Transcriptome profiling revealed the potential mechanisms of Shen Lin Bai Zhu San n-butanol extract on DSS induced colitis in mice and LC-MS analysis
10.1016/j.phymed.2023.154645 · doi-reference
POGZ suppresses 2C transcriptional program and retrotransposable elements
10.1016/j.celrep.2023.112867 · doi-reference
Increased serum levels and sinusoidal expression of thrombomodulin in acute liver damage
10.1016/s0049-3848(98)00167-4 · doi-reference
A potential role for SerpinA3N in acetaminophen-induced hepatotoxicity
10.1124/molpharm.120.000117 · doi-reference
SerpinA3N deficiency attenuates steatosis and enhances insulin signaling in male mice
10.1530/joe-22-0073 · doi-reference
Melatonin alleviates PM2.5-induced glucose metabolism disorder and lipidome alteration by regulating endoplasmic reticulum stress
10.1111/jpi.12823 · doi-reference
Creld2 function during unfolded protein response is essential for liver metabolism homeostasis
10.1096/fj.202002713rr · doi-reference
Gene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmium
10.1016/j.taap.2015.08.011 · doi-reference
LncRNA-URHC functions as ceRNA to regulate DNAJB9 expression by competitively binding to miR-5007-3p in hepatocellular carcinoma
10.1155/2023/9789637 · doi-reference
Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR
10.1038/s41598-019-46161-4 · doi-reference
Herp knockout protects against nonalcoholic fatty liver disease in mice on a high fat diet
10.1002/kjm2.12349 · doi-reference
Corosolic acid sensitizes ferroptosis by upregulating HERPUD1 in liver cancer cells
10.1038/s41420-022-01169-0 · doi-reference